Lee Cooper

ORCID: 0000-0002-3504-4965
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • AI in cancer detection
  • Radiomics and Machine Learning in Medical Imaging
  • Cell Image Analysis Techniques
  • Glioma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Medical Image Segmentation Techniques
  • Digital Imaging for Blood Diseases
  • Single-cell and spatial transcriptomics
  • Cancer Immunotherapy and Biomarkers
  • Ferroptosis and cancer prognosis
  • Advanced MRI Techniques and Applications
  • Bioinformatics and Genomic Networks
  • Dental materials and restorations
  • Cancer-related molecular mechanisms research
  • Dental Erosion and Treatment
  • Pregnancy and preeclampsia studies
  • Medical Imaging Techniques and Applications
  • Genetics, Bioinformatics, and Biomedical Research
  • Hematological disorders and diagnostics
  • Artificial Intelligence in Healthcare and Education
  • Gene expression and cancer classification
  • Image Retrieval and Classification Techniques
  • Cancer Cells and Metastasis
  • Computational Drug Discovery Methods
  • Advanced Neural Network Applications

Emory University
2011-2025

Northwestern University
2019-2025

University of Miami
2025

Duke University
2025

University of Liverpool
2009-2025

McCormick (United States)
2023-2024

RELX Group (United States)
2023-2024

Northwestern University
2024

Brigham and Women's Hospital
2023

Northwestern Medicine
2022

Daniel J. Brat Roel G.W. Verhaak Kenneth D. Aldape W. K. Alfred Yung Sofie R. Salama and 95 more Lee Cooper Esther Rheinbay C. Ryan Miller Mark Vitucci Olena Morozova A. Gordon Robertson Houtan Noushmehr Peter W. Laird Andrew D. Cherniack Rehan Akbani Jason T. Huse Giovanni Ciriello Laila Poisson Jill S. Barnholtz‐Sloan Mitchel S. Berger Cameron Brennan Rivka R. Colen Howard Colman Adam E. Flanders Caterina Giannini Mia Grifford Antonio Iavarone Rajan Jain Isaac Joseph Jaegil Kim L. Sylvia Tom Mikkelsen Bradley A. Murray Brian Patrick O’Neill Lior Pachter D. Williams Parsons Carrie Sougnez Erik P. Sulman Scott R. VandenBerg Erwin G. Van Meir Andreas von Deimling Hailei Zhang Daniel Crain Kevin Lau David Mallery Scott Morris Joseph Paulauskis Robert Penny Troy Shelton Mark E. Sherman Peggy Yena Aaron Black Jay Bowen Katie Dicostanzo Julie M. Gastier‐Foster Kristen Leraas Tara M. Lichtenberg Christopher R. Pierson Nilsa C. Ramirez Cynthia Taylor Stephanie Weaver Lisa Wise Erik Zmuda Tanja M. Davidsen John A. Demchok Greg Eley Martin L. Ferguson Carolyn M. Hutter Kenna Shaw Bradley A. Ozenberger Margi Sheth Heidi J. Sofia Roy Tarnuzzer Linghua Wang Liming Yang Jean C. Zenklusen Brenda Ayala Julien Baboud Sudha Chudamani Mark A. Jensen Jia Liu Todd Pihl Rohini Raman Yunhu Wan Ye Wu Adrian Ally J. Todd Auman Miruna Balasundaram Saianand Balu Stephen B. Baylin Rameen Beroukhim Arnoud Boot Reanne Bowlby Christopher A. Bristow Denise Brooks Yaron S.N. Butterfield Rebecca Carlsen Scott L. Carter Lynda Chin Andy Chu

Diffuse low-grade and intermediate-grade gliomas (which together make up the lower-grade gliomas, World Health Organization grades II III) have highly variable clinical behavior that is not adequately predicted on basis of histologic class. Some are indolent; others quickly progress to glioblastoma. The uncertainty compounded by interobserver variability in diagnosis. Mutations IDH, TP53, ATRX codeletion chromosome arms 1p 19q (1p/19q codeletion) been implicated as clinically relevant...

10.1056/nejmoa1402121 article EN New England Journal of Medicine 2015-06-11
Michele Ceccarelli Floris P Barthel Tathiane M. Malta Thaís S. Sabedot Sofie R. Salama and 95 more Bradley A. Murray Olena Morozova Yulia Newton Amie Radenbaugh Stefano Maria Pagnotta Samreen Anjum Jiguang Wang Ganiraju C. Manyam Pietro Zoppoli Shiyun Ling Arjun A. Rao Mia Grifford Andrew D. Cherniack Hailei Zhang Laila Poisson Carlos Gilberto Carlotti Daniela Pretti da Cunha Tirapelli Arvind Rao Tom Mikkelsen Ching C. Lau W. K. Alfred Yung Raúl Rabadán Jason T. Huse Daniel J. Brat Norman L. Lehman Jill S. Barnholtz‐Sloan Siyuan Zheng Kenneth R. Hess Ganesh Rao Matthew Meyerson Rameen Beroukhim Lee Cooper Rehan Akbani Margaret Wrensch David Haussler Kenneth D. Aldape Peter W. Laird David H. Gutmann Houtan Noushmehr Antonio Iavarone Roel G.W. Verhaak Samreen Anjum Harindra Arachchi J. Todd Auman Miruna Balasundaram Saianand Balu Gene H. Barnett Stephen Baylin Sue Bell Christopher C. Benz Natalie Bir Keith L. Black Tom Bodenheimer Lori Boice Arnoud Boot Jay Bowen Christopher A. Bristow Yaron S.N. Butterfield Qingrong Chen Lynda Chin Juok Cho Eric Chuah Sudha Chudamani Simon G. Coetzee Mark L. Cohen Howard Colman Marta Couce Fulvio D’Angelo Tanja M. Davidsen Amy Davis John A. Demchok Karen Devine Li Ding Rebecca Duell J. Bradley Elder Jennifer Eschbacher Ashley Fehrenbach Martin L. Ferguson Scott Frazer Gregory N. Fuller Jordonna Fulop Stacey Gabriel Luciano Garofano Julie M. Gastier-Foster Nils Gehlenborg Mark Gerken Gad Getz Caterina Giannini William J. Gibson Angela Hadjipanayis D. Neil Hayes David I. Heiman Beth Hermes Joe Hilty Katherine A. Hoadley

10.1016/j.cell.2015.12.028 article EN publisher-specific-oa Cell 2016-01-01

Significance Predicting the expected outcome of patients diagnosed with cancer is a critical step in treatment. Advances genomic and imaging technologies provide physicians vast amounts data, yet prognostication remains largely subjective, leading to suboptimal clinical management. We developed computational approach based on deep learning predict overall survival brain tumors from microscopic images tissue biopsies biomarkers. This method uses adaptive feedback simultaneously learn visual...

10.1073/pnas.1717139115 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2018-03-12

Abstract Inhibition of vascular endothelial growth factor-A (VEGF) signaling is a promising therapeutic approach that aims to stabilize the progression solid malignancies by abrogating tumor-induced angiogenesis. This may be accomplished inhibiting kinase activity VEGF receptor-2 (KDR), which has key role in mediating VEGF-induced responses. The novel indole-ether quinazoline AZD2171 highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor recombinant KDR tyrosine vitro. Concordant...

10.1158/0008-5472.can-04-4409 article EN Cancer Research 2005-05-15

Purpose To conduct a comprehensive analysis of radiologist-made assessments glioblastoma (GBM) tumor size and composition by using community-developed controlled terminology magnetic resonance (MR) imaging visual features as they relate to genetic alterations, gene expression class, patient survival. Materials Methods Because all study patients had been previously deidentified the Cancer Genome Atlas (TCGA), publicly available data set that contains no linkage identifiers is HIPAA compliant,...

10.1148/radiol.13120118 article EN Radiology 2013-02-08

Abstract Purpose: Lower-grade gliomas (WHO grade II/III) have been classified into clinically relevant molecular subtypes based on IDH and 1p/19q mutation status. The purpose was to investigate whether T2/FLAIR MRI features could distinguish between lower-grade glioma subtypes. Experimental Design: scans from the TCGA/TCIA lower database (n = 125) were evaluated by two independent neuroradiologists assess (i) presence/absence of homogenous signal T2WI; (ii) “T2–FLAIR mismatch” sign; (iii)...

10.1158/1078-0432.ccr-17-0560 article EN Clinical Cancer Research 2017-07-28

Visual morphology assessment is routinely used for evaluating of embryo quality and selecting human blastocysts transfer after in vitro fertilization (IVF). However, the produces different results between embryologists as a result, success rate IVF remains low. To overcome uncertainties quality, multiple embryos are often implanted resulting undesired pregnancies complications. Unlike other imaging fields, embryology have not yet leveraged artificial intelligence (AI) unbiased, automated...

10.1038/s41746-019-0096-y article EN cc-by npj Digital Medicine 2019-04-04
Frederick S. Varn Kevin C. Johnson Jan Martínek Jason T. Huse MacLean P. Nasrallah and 95 more Pieter Wesseling Lee Cooper Tathiane M. Malta Taylor Wade Thaís S. Sabedot Daniel J. Brat Peter V. Gould Adelheid Wöehrer Kenneth Aldape Azzam Ismail Santhosh Sivajothi Floris P Barthel Hoon Kim Emre Kocakavuk Nazia Ahmed Kieron White Indrani Datta Hyo-Eun Moon Steven Pollock Christine N. Goldfarb Ga-Hyun Lee Luciano Garofano Kevin Anderson Djamel Nehar-Belaid Jill S. Barnholtz‐Sloan Spyridon Bakas Annette T. Byrne Fulvio D’Angelo Hui Gan Mustafa Khasraw Simona Migliozzi D. Ryan Ormond Sun Ha Paek Erwin G. Van Meir Annemiek Walenkamp Colin Watts Tobias Weiß Michael Weller Karolina Palucka Lucy F. Stead Laila Poisson Houtan Noushmehr Antonio Iavarone Roel G.W. Verhaak Frederick S. Varn Kevin C. Johnson Jan Martínek Jason T. Huse MacLean P. Nasrallah Pieter Wesseling Lee Cooper Tathiane M. Malta Taylor Wade Thaís S. Sabedot Daniel J. Brat Peter V. Gould Adelheid Wöehrer Kenneth Aldape Azzam Ismail Santhosh Sivajothi Floris P Barthel Hoon Kim Emre Kocakavuk Nazia Ahmed Kieron White Indrani Datta Hyo-Eun Moon Steven Pollock Christine N. Goldfarb Ga-Hyun Lee Luciano Garofano Kevin Anderson Djamel Nehar-Belaid Jill S. Barnholtz‐Sloan Spyridon Bakas Annette T. Byrne Fulvio D’Angelo Hui Gan Mustafa Khasraw Simona Migliozzi D. Ryan Ormond Sun Ha Paek Erwin G. Van Meir Annemiek Walenkamp Colin Watts Tobias Weiß Michael Weller Kristin Alfaro-Munoz Samirkumar B. Amin David M. Ashley Christoph Bock Andrew Brodbelt Ketan R. Bulsara Ana Valéria Castro Jennifer Connelly

10.1016/j.cell.2022.04.038 article EN publisher-specific-oa Cell 2022-05-31

Artificial Intelligence (AI) is having a tremendous impact across most areas of science. Applications AI in healthcare have the potential to improve our ability detect, diagnose, prognose, and intervene on human disease. For models be used clinically, they need made safe, reproducible robust, underlying software framework must aware particularities (e.g. geometry, physiology, physics) medical data being processed. This work introduces MONAI, freely available, community-supported,...

10.48550/arxiv.2211.02701 preprint EN cc-by arXiv (Cornell University) 2022-01-01

The Cancer Genome Atlas (TCGA) project has generated gene expression data that divides glioblastoma (GBM) into four transcriptional classes: proneural, neural, classical, and mesenchymal. Because class is only partially explained by underlying genomic alterations, we hypothesize the tumor microenvironment may also have an impact. In this study, focused on necrosis angiogenesis because their presence both prognostically biologically significant. These features were quantified in digitized...

10.1016/j.ajpath.2012.01.040 article EN cc-by-nc-nd American Journal Of Pathology 2012-03-20

While deep-learning algorithms have demonstrated outstanding performance in semantic image segmentation tasks, large annotation datasets are needed to create accurate models. Annotation of histology images is challenging due the effort and experience required carefully delineate tissue structures, difficulties related sharing markup whole-slide images.We recruited 25 participants, ranging from senior pathologists medical students, regions 151 breast cancer slides using Digital Slide Archive....

10.1093/bioinformatics/btz083 article EN cc-by Bioinformatics 2019-02-05

Abstract Translating the vast data generated by genomic platforms into accurate predictions of clinical outcomes is a fundamental challenge in medicine. Many prediction methods face limitations learning from high-dimensional profiles these platforms, and rely on experts to hand-select small number features for training models. In this paper, we demonstrate how deep Bayesian optimization that have been remarkably successful general tasks can be adapted problem predicting cancer outcomes. We...

10.1038/s41598-017-11817-6 article EN cc-by Scientific Reports 2017-09-11

Abstract As genomics advances reveal the cancer gene landscape, a daunting task is to understand how these genes contribute dysregulated oncogenic pathways. Integration of into networks offers opportunities protein–protein interactions (PPIs) with functional and therapeutic significance. Here, we report generation cancer-focused PPI network, termed OncoPPi, identification >260 cancer-associated PPIs not in other large-scale interactomes. hubs new regulatory mechanisms for like MYC , STK11...

10.1038/ncomms14356 article EN cc-by Nature Communications 2017-02-16
Zuzana Kos Elvire Roblin Rim S. Kim Stefan Michiels Brandon D. Gallas and 95 more Weijie Chen Koen Van de Vijver Shom Goel Sylvia Adams Sandra Demaria Giuseppe Viale Torsten O. Nielsen Sunil Badve W. Fraser Symmans Christos Sotiriou David L. Rimm Stephen M. Hewitt Carsten Denkert Sibylle Loibl Stephen J. Luen Thomas John Peter Savas Giancarlo Pruneri Deborah Dillon Maggie C.U. Cheang Andrew Tutt Jacqueline A. Hall Marleen Kok Hugo M. Horlings Anant Madabhushi Jeroen van der Laak Francesco Ciompi Anne‐Vibeke Lænkholm Enrique Bellolio Tina Gruosso Stephen B. Fox Juan Carlos Araya Giuseppe Floris Jan Hudeček Leonie Voorwerk Andrew H. Beck J. Kaplan Kerner Denis Larsimont Sabine Declercq Gert Van den Eynden Lajos Pusztai Anna Ehinger Wentao Yang Khalid AbdulJabbar Yinyin Yuan Rajendra Singh Crispin T. Hiley Maise Al Bakir Alexander J. Lazar Stephen P. Naber Stephan Wienert Miluska Castillo Giuseppe Curigliano Maria Vittoria Dieci Fabrice André Charles Swanton Jorge S. Reis‐Filho Joseph A. Sparano Eva Balslev I‐Chun Chen Elisabeth Ida Specht Stovgaard Katherine L. Pogue‐Geile Kim Blenman Frédérique Penault–Llorca Stuart J. Schnitt Sunil R. Lakhani Anne Vincent‐Salomon Federico Rojo Jeremy Braybrooke Matthew G. Hanna María Teresa Soler-Monsó Daniel Bethmann Carlos Castaneda Karen Willard‐Gallo Ashish Sharma Huang‐Chun Lien Susan Fineberg Jeppe Thagaard Laura Comerma Paula I. González-Ericsson Edi Brogi Sherene Loi Joel Saltz Frederick Klaushen Lee Cooper Mohamed Amgad David Moore Roberto Salgado Aini Hyytiäinen Akira I. Hida Alastair Thompson Alex Lefevre Allen M. Gown Sadis Matalon Anna Sapino

Abstract Stromal tumor-infiltrating lymphocytes (sTILs) are important prognostic and predictive biomarkers in triple-negative (TNBC) HER2-positive breast cancer. Incorporating sTILs into clinical practice necessitates reproducible assessment. Previously developed standardized scoring guidelines have been widely embraced by the research communities. We evaluated sources of variability sTIL assessment pathologists three previous ring studies. identify common challenges evaluate impact...

10.1038/s41523-020-0156-0 article EN cc-by npj Breast Cancer 2020-05-12

Tumor-infiltrating lymphocytes (TIL) have prognostic significance in many cancers, yet their roles glioblastoma not been fully defined. We hypothesized that TILs are associated with molecular alterations, histologies, and survival.

10.1158/1078-0432.ccr-13-0551 article EN Clinical Cancer Research 2013-07-18

Background The integration and visualization of multimodal datasets is a common challenge in biomedical informatics. Several recent studies Cancer Genome Atlas (TCGA) data have illustrated important relationships between morphology observed whole-slide images, outcome, genetic events. pairing genomics rich clinical descriptions with imaging provided by TCGA presents unique opportunity to perform these correlative studies. However, better tools are needed integrate the vast disparate types.

10.1136/amiajnl-2012-001469 article EN Journal of the American Medical Informatics Association 2013-07-27

Tissue-based cancer studies can generate large amounts of histology data in the form glass slides. These slides contain important diagnostic, prognostic, and biological information be digitized into expansive high-resolution whole-slide images using slide-scanning devices. Effectively utilizing digital pathology research requires ability to manage, visualize, share, perform quantitative analysis on these image data, tasks that are often complex difficult for investigators with current state...

10.1158/0008-5472.can-17-0629 article EN Cancer Research 2017-10-31

The Cancer Genome Atlas Project (TCGA) has produced an extensive collection of '-omic' data on glioblastoma (GBM), resulting in several key insights expression signatures. Despite the richness TCGA GBM data, absence lower grade gliomas this set prevents analysis genes related to progression and uncovering predictive A complementary dataset exists form NCI Repository for Molecular Brain Neoplasia Data (Rembrandt), which contains molecular clinical diffuse across full spectrum histologic class...

10.1371/journal.pone.0012548 article EN cc-by PLoS ONE 2010-09-03

Abstract Phenotypic heterogeneity is widely observed in cancer cell populations. Here, to probe this heterogeneity, we developed an image-guided genomics technique termed spatiotemporal genomic and cellular analysis (SaGA) that allows for precise selection amplification of living rare cells. SaGA was used on collectively invading 3D packs create purified leader follower lines. The cultures are phenotypically stable highly invasive contrast cultures, which show phenotypic plasticity over time...

10.1038/ncomms15078 article EN cc-by Nature Communications 2017-05-12

The standard of care for glioblastoma (GBM) is maximal safe resection followed by radiation therapy with chemotherapy. Currently, contrast-enhanced MRI used to define primary treatment volumes surgery and therapy. However, enhancement does not identify the tumor entirely, resulting in limited local control. Proton spectroscopic (sMRI), a method reporting endogenous metabolism, may better margin. Here, we develop whole-brain sMRI pipeline validate metrics quantitative measures infiltration....

10.1093/neuonc/now036 article EN Neuro-Oncology 2016-03-15

Pathologic review of tumor morphology in histologic sections is the traditional method for cancer classification and grading, yet human has limitations that can result low reproducibility inter-observer agreement. Computerized image analysis partially overcome these shortcomings due to its capacity quantitatively reproducibly measure structures on a large-scale. In this paper, we present an end-to-end data integration pipeline large-scale morphologic pathology images demonstrate ability...

10.1371/journal.pone.0081049 article EN cc-by PLoS ONE 2013-11-13
Coming Soon ...